Remember when I said we were just getting started? Well, here we go... PHASE 2: COA ACCOUNTABILITY Just rolled out new standards that are going to separate the real players from the pretenders. Every vendor on peptideprice.store now has to follow one simple rule: COAs must be under 6 months old. Period. Why this is HUGE: - No more recycling old test results - No more "trust me bro" on batch quality - No more cutting corners while you pay full price - Forces real transparency, not just marketing talk Here's what was happening: Rumors were spreading that some companies reorder the same cap colors to avoid testing new batches. Basically gaming the system while customers think they're getting fresh, tested product. My response: October 31st deadline. Comply or get removed. No exceptions. New Policy (Effective Oct 31st): ✅ All COAs must be dated within the last 6 months ✅ Applies to every product on peptideprice.store ✅ If selling batches older than 6 months = retesting required Phase 2 is about ACCOUNTABILITY. Making sure those standards actually mean something. Companies doing things right? This makes them stronger. Companies cutting corners? They're about to find out this isn't the wild west anymore. The industry is changing whether some companies like it or not. I'm just making sure peptideprice.store represents the future, not the past. Read the full email Attached Below 👇 ------------------------------------------ To All Research Companies, I'm reaching out regarding a critical issue that's been brought to my attention by multiple customers and industry contacts. There have been persistent rumors circulating that some companies are reusing old COAs and avoiding batch testing by strategically reordering identical cap and crimp colors to maintain the appearance of consistent inventory. The Issue: I want to be clear—I've had great experiences with all of you and don't believe anyone here is engaging in this practice. However, the concern is real and must be addressed. Customers are worried that companies may be bypassing proper testing protocols to save on the time and expense of retesting new batches. This not only undermines customer trust but also poses real risks, since new batches can vary significantly in purity and net peptide content regardless of packaging.

Any guesses?